These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 23236591

  • 1. [The treatment of castration-resistant prostate cancer].
    Petrányi Á.
    Magy Onkol; 2012 Dec; 56(4):219-28. PubMed ID: 23236591
    [Abstract] [Full Text] [Related]

  • 2. Novel molecular targets for the therapy of castration-resistant prostate cancer.
    Agarwal N, Sonpavde G, Sternberg CN.
    Eur Urol; 2012 May; 61(5):950-60. PubMed ID: 22209376
    [Abstract] [Full Text] [Related]

  • 3. Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities.
    Payne H, Bahl A, Mason M, Troup J, De Bono J.
    BJU Int; 2012 Sep; 110(5):658-67. PubMed ID: 22429837
    [Abstract] [Full Text] [Related]

  • 4. [New drugs in metastatic castration-resistant prostate cancer].
    Albiges L, Loriot Y, Gross-Goupil M, de La Motte Rouge T, Blesius A, Escudier B, Massard C, Fizazi K.
    Bull Cancer; 2010 Jan; 97(1):149-59. PubMed ID: 20022854
    [Abstract] [Full Text] [Related]

  • 5. Novel and bone-targeted agents for CRPC.
    Fizazi K, Albiges L, Massard C, Escudier B, Loriot Y.
    Ann Oncol; 2012 Sep; 23 Suppl 10():x264-7. PubMed ID: 22987974
    [Abstract] [Full Text] [Related]

  • 6. Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer.
    MacVicar GR, Hussain MH.
    Curr Opin Oncol; 2013 May; 25(3):252-60. PubMed ID: 23511665
    [Abstract] [Full Text] [Related]

  • 7. [Strategy in advanced castration-resistant prostate cancer].
    Gross-Goupil M, Roca S, Pasticier G, Ravaud A.
    Bull Cancer; 2012 Jul; 99 Suppl 1():S37-45. PubMed ID: 22522582
    [Abstract] [Full Text] [Related]

  • 8. New treatment options for patients with metastatic castration-resistant prostate cancer.
    Higano CS.
    Cancer Treat Rev; 2012 Aug; 38(5):340-5. PubMed ID: 21944872
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New agents for prostate cancer.
    Agarwal N, Di Lorenzo G, Sonpavde G, Bellmunt J.
    Ann Oncol; 2014 Sep; 25(9):1700-1709. PubMed ID: 24658665
    [Abstract] [Full Text] [Related]

  • 11. [New therapies in metastatic castration resistant prostate cancer].
    Thibault C, Massard C.
    Bull Cancer; 2015 Jun; 102(6):501-8. PubMed ID: 26022286
    [Abstract] [Full Text] [Related]

  • 12. Emerging targeted therapies for castration-resistant prostate cancer.
    Adamo V, Noto L, Franchina T, Chiofalo G, Picciotto M, Toscano G, Caristi N.
    Front Endocrinol (Lausanne); 2012 Jun; 3():73. PubMed ID: 22666217
    [Abstract] [Full Text] [Related]

  • 13. New developments in castrate-resistant prostate cancer.
    Shore N, Mason M, de Reijke TM.
    BJU Int; 2012 Jun; 109 Suppl 6():22-32. PubMed ID: 22672122
    [Abstract] [Full Text] [Related]

  • 14. [Novel agents for the therapy of castration-resistant prostate cancer: overview of pivotal studies and new strategies to come].
    Ouzaid I, Ravery V, Pouessel D, Culine S.
    Prog Urol; 2013 Jan; 23(1):1-7. PubMed ID: 23287477
    [Abstract] [Full Text] [Related]

  • 15. Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel setting.
    Sartor O, Michels RM, Massard C, de Bono JS.
    Oncologist; 2011 Jan; 16(11):1487-97. PubMed ID: 22048000
    [Abstract] [Full Text] [Related]

  • 16. Systemic therapy in men with metastatic castration-resistant prostate cancer: a systematic review.
    Loblaw DA, Walker-Dilks C, Winquist E, Hotte SJ, Genitourinary Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care.
    Clin Oncol (R Coll Radiol); 2013 Jul; 25(7):406-30. PubMed ID: 23587782
    [Abstract] [Full Text] [Related]

  • 17. New treatment options for castration-resistant prostate cancer.
    Simondsen K, Kolesar J.
    Am J Health Syst Pharm; 2013 May 15; 70(10):856-65. PubMed ID: 23640346
    [Abstract] [Full Text] [Related]

  • 18. Novel options for the treatment of castration-resistant prostate cancer.
    Ohlmann CH, Merseburger AS, Suttmann H, Schilling D, Trojan L, Kempkensteffen C, Corvin S, Mathers MJ, Bastian PJ.
    World J Urol; 2012 Aug 15; 30(4):495-503. PubMed ID: 22101903
    [Abstract] [Full Text] [Related]

  • 19. [Castration resistant prostate cancer 2011].
    Miller K.
    Aktuelle Urol; 2011 Mar 15; 42(2):95-102. PubMed ID: 21437832
    [Abstract] [Full Text] [Related]

  • 20. Metastatic hormone refractory prostate cancer: recent advances in standard treatment paradigm, and future directions.
    Keizman D, Maimon N, Gottfried M.
    Am J Clin Oncol; 2014 Jun 15; 37(3):289-96. PubMed ID: 22772426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.